期刊文献+

超敏C反应蛋白联合血脂检测对诊断冠状动脉硬化的意义 被引量:2

High sensitive C reactive protein combined with blood lipid in the diagnosis of coronary artery atherosclerosis
下载PDF
导出
摘要 目的:探讨超敏C反应蛋白(hs-CRP)、血脂与心血管疾病的相关性。方法:采用酶法检测血清CHOL、TG、HDL-C、LDL-C;采用乳胶增强免疫(超敏)比浊法检测血清hs-CRP,活动平板运动试验结果由心电图室提供。结果:活动平板试验阳性人群血脂水平异常增高,预示着心血管疾病的爆发和一些潜在的危险原因。结论:健康人在平时的体检中应该增加对心血管标准指数的测定,能够起到一定的预测病理风险的作用。 Objective:To investigate the correlation between hs-CRP,blood lipid and cardiovascular disease.Methods:Using enzymic method in detecting of serum CHOL,TG,HDL-C and LDL-C;using latex enhanced immune turbidimetric method(supersensitivity) in the detection of serum hs-CRP,turbidity,and the treadmill exercise test results provided by electrocardiogram room.Results:The population with positive result of treadmill exercise test had abnormally increased blood lipid level,which indicated that cardiovascular disease outbreaks had relationship with some potential risk.Conclusion:The determination of cardiovascular standard index should be added in normal physical examination of healthy people.It can play a certain role in forecasting risk prediction.
作者 吕占清 谷菲
机构地区 吉林省脑科医院
出处 《中国社区医师》 2015年第17期106-106,108,共2页 Chinese Community Doctors
关键词 心律平板活动试验 心血管病变 超敏C反应蛋白 血脂 Treadmill exercise electrocardiography test Cardiovascular disease High sensitivity C reactive protein Blood lipid
  • 相关文献

参考文献4

二级参考文献40

共引文献13

同被引文献31

  • 1李桂源.病理生理学[M].北京:人民卫生出版社,2005.236-240.
  • 2Roberts R. PCSK9 inhibition-a new thrust in the prevention ofheart disease:genetics does it again[J]. Can J Cardiol,2013,29(8):899-901.
  • 3Xu RX,Li S,Zhang Y,et al. Relation of plasma PCSK9 levelsto lipoprotein subfractions in patients with stable coronaryartery disease[j]. Lipids Health Dis,2014,13 : 188-204.
  • 4Abifadel M,Guerin M, Benjannet S, et al. Identification andcharacterization of new gain-of-function mutations in thePCSK9 gene responsible for autosomal dominanthypercholesterolemia[ JD. Atherosclerosis, 2012,223 ( 2) : 394-400.
  • 5Kosenko T, Golder M, Leblond G,et al. Low densitylipoprotein binds to proprotein convertase subtilisin/kexintype-9 (PCSK9) in human plasma and inhibits PCSK9-mediatedlow density lipoprotein receptor degradation[J]. J Biol Chem,2013,288(12):8279-8288.
  • 6Leren TP. Sorting an LDL receptor with bound PCSK9 tointracellular degradation[J], Atherosclerosis, 2014,237(1) :76-81.
  • 7Araki S,Suga S,Miyake F,et al. Circulating PCSK9 levelscorrelate with the serum LDL cholesterol level in newborninfants[J]_ Early Hum Dev,2014,90(10) :607-611.
  • 8Kwakernaak AJ, Lambert G,Dullaart RP. Plasma proproteinconvertase subtilisin-kexin type 9 is predominantly related tointermediate density lipoproteins [J]. Clin Biochem, 2014, 47(7/8):679-682.
  • 9Werner C,Hoffmann MM, Winkler K, et al. Risk predictionwith proprotein convertase subtilisin/kexin type 9 (PCSK9)inpatients with stable coronary disease on statin treatment [J].Vase Pharmacol,2014,62(2) :94-102.
  • 10Wu Q,Tang ZH,Peng J,et al. The dual behavior of PCSK9 inthe regulation of apoptosis is crucial in Alzheimer's diseaseprogression (Review)[J]. Biomed Rep,2014,2(2) : 167-171.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部